ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Fellowships In Japan Available Through NIH

October 13, 1995